How much protein do you need on a GLP-1?

Appetite suppression makes protein harder to obtain, not less important. Here is the evidence behind common targets and why the right number depends on you.

By Peptis Publication · 2026-08-21 · 6 minute read · Education only

Why appetite changes the problem

Semaglutide lowers appetite and energy intake. In controlled appetite studies, ad libitum daily energy intake was 24% lower after 12 weeks at diabetes-range dosing, and a separate semaglutide 2.4 mg study found 35% lower ad libitum meal intake than placebo. These short mechanistic trials do not predict any individual long-term deficit, but they explain why protein-dense foods matter more when total food volume falls.

The problem is not that every user becomes deficient. Lower food volume simply leaves less margin for a diet built around low-protein snacks, alcohol, sweets or skipped meals.

What the evidence supports

Higher-protein energy-restricted diets can preserve more fat-free mass than the 0.8 g/kg/day RDA pattern, especially with resistance exercise. Reviews commonly identify 1.2 to 1.6 g/kg/day as a useful range for active weight management, with 25 to 30 g per meal as a practical distribution target.

The denominator problem

For people with obesity, multiplying a high target by current body weight can produce an unnecessarily large number. A clinician or dietitian may instead use goal weight, ideal body weight, adjusted body weight or measured lean mass. No single denominator fits everyone, and kidney disease, liver disease, pregnancy and other conditions require individual clinical guidance.

Practical structure when food volume is low

Food comes first when you can tolerate it. Smaller, protein-forward eating occasions usually work better than forcing one large meal. Low-volume options include Greek yogurt, eggs, fish, poultry, tofu and cottage cheese. A complete protein serving of about 20 to 25 g can close a gap on days when food does not appeal, and it supports training rather than replacing it.

What the evidence cannot tell us

  • These ranges come from general active weight loss research, not GLP-1 specific dosing trials.
  • No review can set your personal target; medical conditions change the answer.

Sources

  1. Blundell et al., Diabetes, Obesity and Metabolism, 2017, dossier [19]
  2. Friedrichsen et al., Diabetes, Obesity and Metabolism, 2021, dossier [20]
  3. Nunes et al., Sports Medicine, 2022, dossier [24]
  4. Leidy et al., American Journal of Clinical Nutrition, 2015, dossier [25]
  5. Mozaffarian et al., joint nutrition advisory, American Journal of Clinical Nutrition, 2025, dossier [17]

Keep reading

    Talk with your current clinician before changing medication, diet, supplements or exercise.

    Get your free continuity summary